James C Barton1,2, Jackson Clayborn Barton1, Ronald T Acton1,3. 1. 1 Southern Iron Disorders Center , Birmingham, Alabama. 2. 2 Department of Medicine, University of Alabama at Birmingham , Birmingham, Alabama. 3. 3 Department of Microbiology, University of Alabama at Birmingham , Birmingham, Alabama.
Abstract
BACKGROUND: We sought to determine associations with insulin resistance (IR) and metabolic syndrome (MetS) in African Americans. METHODS: We studied African American adults without diabetes in a postscreening examination. Participants included Cases: transferrin saturation (TS) >50% and serum ferritin (SF) >300 μg/L (M), and TS >45% and SF >200 μg/L (F), regardless of HFE genotype; and Controls: TS/SF 25th to 75th percentiles and HFE wt/wt (wild type). We excluded participants with fasting <8 h; fasting glucose >126 mg/dL; hepatitis B or C; cirrhosis; pregnancy; or incomplete datasets. We analyzed age; sex; Case/Control; body mass index (BMI); systolic and diastolic blood pressures; neutrophils; lymphocytes; alanine aminotransferase; aspartate aminotransferase; elevated C-reactive protein (CRP >0.5 mg/L); TS; and SF. We computed homeostasis model assessment of insulin resistance (HOMA-IR) using fasting serum glucose and insulin, and defined IR as HOMA-IR fourth quartile (≥2.42). RESULTS: There were 312 Cases and 86 Controls (56.3% men). Ninety-one percent had HFE wt/wt. None had HFE p.C282Y. A significant increasing trend across HOMA-IR quartiles was observed for BMI only. Multivariable regression on HOMA-IR revealed significant positive associations: age; BMI; lymphocytes; SF; and CRP >0.5 mg/L; and significant negative associations: neutrophils and TS. Logistic regression on IR revealed BMI [odds ratio (OR) 1.3 (95% confidence interval 1.2-1.4)] and CRP >0.5 mg/L [OR 2.7 (1.2-6.3)]. Fourteen participants (3.5%) had MetS. Logistic regression on MetS revealed one association: IR [OR 7.4 (2.1-25.2)]. CONCLUSIONS: In African Americans without diabetes, IR was associated with BMI and CRP >0.5 mg/L, after adjustment for other variables. MetS was associated with IR alone.
BACKGROUND: We sought to determine associations with insulin resistance (IR) and metabolic syndrome (MetS) in African Americans. METHODS: We studied African American adults without diabetes in a postscreening examination. Participants included Cases: transferrin saturation (TS) >50% and serum ferritin (SF) >300 μg/L (M), and TS >45% and SF >200 μg/L (F), regardless of HFE genotype; and Controls: TS/SF 25th to 75th percentiles and HFE wt/wt (wild type). We excluded participants with fasting <8 h; fasting glucose >126 mg/dL; hepatitis B or C; cirrhosis; pregnancy; or incomplete datasets. We analyzed age; sex; Case/Control; body mass index (BMI); systolic and diastolic blood pressures; neutrophils; lymphocytes; alanine aminotransferase; aspartate aminotransferase; elevated C-reactive protein (CRP >0.5 mg/L); TS; and SF. We computed homeostasis model assessment of insulin resistance (HOMA-IR) using fasting serum glucose and insulin, and defined IR as HOMA-IR fourth quartile (≥2.42). RESULTS: There were 312 Cases and 86 Controls (56.3% men). Ninety-one percent had HFE wt/wt. None had HFEp.C282Y. A significant increasing trend across HOMA-IR quartiles was observed for BMI only. Multivariable regression on HOMA-IR revealed significant positive associations: age; BMI; lymphocytes; SF; and CRP >0.5 mg/L; and significant negative associations: neutrophils and TS. Logistic regression on IR revealed BMI [odds ratio (OR) 1.3 (95% confidence interval 1.2-1.4)] and CRP >0.5 mg/L [OR 2.7 (1.2-6.3)]. Fourteen participants (3.5%) had MetS. Logistic regression on MetS revealed one association: IR [OR 7.4 (2.1-25.2)]. CONCLUSIONS: In African Americans without diabetes, IR was associated with BMI and CRP >0.5 mg/L, after adjustment for other variables. MetS was associated with IR alone.
Entities:
Keywords:
C-reactive protein; HFE; HOMA-IR; body mass index; serum ferritin
Authors: Jing Chen; Rachel P Wildman; L Lee Hamm; Paul Muntner; Kristi Reynolds; Paul K Whelton; Jiang He Journal: Diabetes Care Date: 2004-12 Impact factor: 19.112
Authors: S M Haffner; G Howard; E Mayer; R N Bergman; P J Savage; M Rewers; L Mykkänen; A J Karter; R Hamman; M F Saad Journal: Diabetes Date: 1997-01 Impact factor: 9.461
Authors: Carson C Chow; Vipul Periwal; Gyorgy Csako; Madia Ricks; Amber B Courville; Bernard V Miller; Gloria L Vega; Anne E Sumner Journal: J Clin Endocrinol Metab Date: 2011-05-18 Impact factor: 5.958
Authors: James C Barton; Ronald T Acton; Fitzroy W Dawkins; Paul C Adams; Laura Lovato; Cathie Leiendecker-Foster; Christine E McLaren; David M Reboussin; Mark R Speechley; Victor R Gordeuk; Gordon D McLaren; Phyliss Sholinsky; Emily L Harris Journal: Genet Test Date: 2005
Authors: David E Laaksonen; Hanna-Maaria Lakka; Leo K Niskanen; George A Kaplan; Jukka T Salonen; Timo A Lakka Journal: Am J Epidemiol Date: 2002-12-01 Impact factor: 4.897